Form 8-K - Current report:
SEC Accession No. 0001193125-18-321016
Filing Date
2018-11-07
Accepted
2018-11-07 16:51:59
Documents
4
Period of Report
2018-11-07
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d650389d8k.htm 8-K 24944
2 EX-99.1 d650389dex991.htm EX-99.1 8533
3 EX-99.2 d650389dex992.htm EX-99.2 23112
4 GRAPHIC g650389g97n70.jpg GRAPHIC 3018
  Complete submission text file 0001193125-18-321016.txt   62362
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 181167045
SIC: 2834 Pharmaceutical Preparations